Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Lori A Ramkissoon"'
Autor:
Nahla A Mobark, Musa Alharbi, Lamees Alhabeeb, Latifa AlMubarak, Rasha Alaljelaify, Mariam AlSaeed, Amal Almutairi, Fatmah Alqubaishi, Maqsood Ahmad, Ayman Al-Banyan, Fahad E Alotabi, Duna Barakeh, Malak AlZahrani, Hisham Al-Khalidi, Abdulrazag Ajlan, Lori A Ramkissoon, Shakti H Ramkissoon, Malak Abedalthagafi
Publikováno v:
PLoS ONE, Vol 15, Iss 1, p e0228356 (2020)
Pediatric Low Grade Gliomas (PLGGs) display heterogeneity regarding morphology, genomic drivers and clinical outcomes. The treatment modality dictates the outcome and optimizing patient management can be challenging. In this study, we profiled a targ
Externí odkaz:
https://doaj.org/article/8d3c77f9ef904f1b90b72245eec9c67a
Autor:
Lori A. Ramkissoon, Worthy Pegram, James Haberberger, Natalie Danziger, Glenn Lesser, Roy Strowd, Sonika Dahiya, Thomas J. Cummings, Wenya Linda Bi, Malak Abedalthagafi, Pratheesh Sathyan, Kimberly McGregor, Prasanth Reddy, Eric Severson, Erik Williams, Douglas Lin, Claire Edgerly, Richard S. P. Huang, Amanda Hemmerich, James Creeden, Charlotte Brown, Jeffrey Venstrom, Priti Hegde, Jeffrey S. Ross, Brian M. Alexander, Julia Elvin, Shakti H. Ramkissoon
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Despite advances in systemic therapies for solid tumors, the development of brain metastases remains a significant contributor to overall cancer mortality and requires improved methods for diagnosing and treating these lesions. Similarly, the prognos
Externí odkaz:
https://doaj.org/article/d0714fbac5434bd29958cf5481928aff
Publikováno v:
Human Immunology. 82:859-870
In the last decade, next-generation sequencing (NGS) has rapidly progressed from a research method to a core component of standard-of-care clinical testing. In oncology, tumor sequencing provides a critical tool to detect somatic driver mutations tha
Autor:
Lori A. Ramkissoon, Kaitlyn Buhlinger, Angela Nichols, Catherine C. Coombs, Matthew C. Foster, Jonathan Galeotti, Kathleen Kaiser-Rogers, Daniel R. Richardson, Nathan D. Montgomery, Joshua F. Zeidner
Publikováno v:
Leukemia & Lymphoma. 62:3035-3038
Autor:
Richard S.P. Huang, James Haberberger, Shakti H. Ramkissoon, Wenya Linda Bi, Pratheesh Sathyan, Lori A. Ramkissoon, Glenn J. Lesser, Roy E. Strowd, Brian M. Alexander, Julia A. Elvin, Kimberly McGregor, Erik A. Williams, Worthy Pegram, Amanda Hemmerich, Eric Allan Severson, Jeffrey S. Ross, James Creeden, Thomas J. Cummings, Claire Edgerly, Jeffrey M. Venstrom, Priti Hegde, Sonika Dahiya, Douglas I. Lin, Charlotte Brown, Prasanth Reddy, Natalie Danziger, Malak Abedalthagafi
Publikováno v:
Frontiers in Neurology
Frontiers in Neurology, Vol 11 (2020)
Frontiers in Neurology, Vol 11 (2020)
Despite advances in systemic therapies for solid tumors, the development of brain metastases remains a significant contributor to overall cancer mortality and requires improved methods for diagnosing and treating these lesions. Similarly, the prognos
Autor:
Vasileios K. Kavouridis, Lori A. Ramkissoon, Omar Arnaout, Joeky T. Senders, Biqi Zhang, Ena Agbodza, Ranjit S. Bindra, Alexandra Capellini, Jane Cryan, Patrick Y. Wen, Chang Su, Bo Xiao, Alessandro Boaro, Shakti Ramkissoon, Qin Shen, Wenya Linda Bi, Li Yang, Elizabeth R. Gerstner, John H. Woo, Raymond Y. Huang, Hao Zhou, Jayashree Kalpathy-Cramer, Paul J. Zhang, Weihua Liao, Keith L. Ligon, Ken Chang, Bruce R. Rosen, Xuejun Li, Andrew Beers, Harrison X. Bai
Publikováno v:
Clinical Cancer Research. 24:1073-1081
Purpose: Isocitrate dehydrogenase (IDH) mutations in glioma patients confer longer survival and may guide treatment decision making. We aimed to predict the IDH status of gliomas from MR imaging by applying a residual convolutional neural network to
Autor:
Lori A. Ramkissoon, Matthew C. Foster, Steven M Johnson, Joshua F. Zeidner, James Haberberger, Shakti H. Ramkissoon, Daniel Duncan, Jeffrey S. Ross, Jonathan Galeotti, Naomi L Ferguson, Nathan D. Montgomery, Daniel R. Richardson
Publikováno v:
Blood. 138:3466-3466
Introduction: ASXL1 mutations are frequently seen across the clinical spectrum of myeloid neoplasia. The most commonly identified ASXL1 mutation represents a single base duplication within an 8-guanine repeat at nucleotide position 1934 (c.1934dupG).
Autor:
Cynthia M. Powell, Kathleen Kaiser-Rogers, Ashley B. Pendleton, Lori A. Ramkissoon, Tam P. Sneddon
Publikováno v:
Molecular Genetics and Metabolism. 132:S246-S247
Autor:
Javier Delgado Blanco, Matty P. Weijenberg, Joost Schymkowitz, Mark S. Hipp, Shakti Ramkissoon, Frederik De Smet, Frédéric Amant, Piet A. van den Brandt, Tobias Langenberg, Keith L. Ligon, André D'Hoore, Filip Claes, Daphne Hompes, Evelyne Naus, Manon Van England, Lori A. Ramkissoon, Greet De Baets, Sandrina Lambrechts, Bert Houben, Xavier Sagaert, Mirian Saiz Rubio, Colinda C. J. M. Simons, Sarah Charbonneau, Stéphane Plaisance, Frederic Rousseau
Publikováno v:
The Journal of Pathology. 242:24-38
Although p53 protein aggregates have been observed in cancer cell lines and tumour tissue, their impact in cancer remains largely unknown. Here, we extensively screened for p53 aggregation phenotypes in tumour biopsies, and identified nuclear inclusi
Autor:
Alicia Brandt, Karen E. Weck, Emily Hardisty, Jonathan S. Berg, Neeta L. Vora, Kirk C. Wilhelmsen, Natasha T. Strande, Bradford C. Powell, Kelly L. Gilmore, Chelsea Gustafson, Cynthia M. Powell, Phillips Owen, Ann Katherine M. Foreman, Lori A. Ramkissoon
Publikováno v:
Genet Med
PURPOSE: We investigated the diagnostic and clinical performance of trio exome sequencing (ES) in parent–fetus trios where the fetus had sonographic abnormalities but normal karyotype, microarray and, in some cases, normal gene-specific sequencing.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bf014263fc6946b0ec96adef8ba15e1
https://europepmc.org/articles/PMC7205580/
https://europepmc.org/articles/PMC7205580/